These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12110402)

  • 1. Estimation of impurity profiles of drugs and related materials: part XXI. HPLC/UV/MS study of the impurity profile of ethynodiol diacetate.
    Babják M; Balogh G; Gazdag M; Görög S
    J Pharm Biomed Anal; 2002 Aug; 29(6):1153-7. PubMed ID: 12110402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of impurity profiles of drugs and related materials. Part VIII: Combined application of high-performance liquid chromatography and NMR spectroscopy in the impurity profiling of drugs.
    Görög S; Balogh G; Gazdag M
    J Pharm Biomed Anal; 1991; 9(10-12):829-33. PubMed ID: 1668302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of steroids. Part 40. Isolation and identification of unusual impurities in ethynodiol diacetate].
    Görög S; Halmos Z; Herényi B; Georgakis A; Balogh G; Csizér E; Tuba Z
    Acta Pharm Hung; 1991 Mar; 61(2):77-81. PubMed ID: 1887802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
    Görög S; Babják M; Balogh G; Brlik J; Dravecz F; Gazdag M; Horváth P; Laukó A; Varga K
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):511-25. PubMed ID: 9919951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of ethynodiol diacetate and ethinyl estradiol/mestranol in oral contraceptive tablets by high-performance liquid chromatography.
    Carignan G; Lodge BA; Skakum W
    J Pharm Sci; 1982 Feb; 71(2):264-6. PubMed ID: 7062257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.
    Görög S; Balogh G; Csehi A; Csizér E; Gazdag M; Halmos Z; Hegedüs B; Herényi B; Horváth P; Laukó A
    J Pharm Biomed Anal; 1993; 11(11-12):1219-26. PubMed ID: 8123737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.
    Görög S; Bihari M; Csizér E; Dravetz F; Gazdag M; Herényi B
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):85-92. PubMed ID: 8833970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol.
    Balogh G; Csizér E; Ferenczy GG; Halmos Z; Herényi B; Horváth P; Laukó A; Görög S
    Pharm Res; 1995 Feb; 12(2):295-8. PubMed ID: 7784348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel reversed-phase HPLC method for simultaneous determination of ethynodiol diacetate (EDA)/ethinyl estradiol (EE) in pharmaceutical dosage form.
    Chinta SR; Ponnam V; Katari NK; Ediga SG; Marisetti VM
    Biomed Chromatogr; 2021 May; 35(5):e5055. PubMed ID: 33368394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, Characterization and High-Performance Liquid Chromatography Quantification for Process-Related Impurities in Abiraterone Acetate Bulk Drug.
    Hu C; Zhang H; Zhang M; Mi Z; Wang J; Lu W; Su J
    J Chromatogr Sci; 2018 Oct; 56(9):802-811. PubMed ID: 30007288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of steroids. XXXVIII. The use of high-performance liquid chromatography with diode-array UV detection for estimating impurity profiles of steroid drugs.
    Görög S; Herényi B
    J Chromatogr; 1987 Jul; 400():177-86. PubMed ID: 3667745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L; Mao B; Reamer R; Novak T; Ge Z
    J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
    Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
    Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
    J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.